Recombinant human bone morphogenetic protein‐2 (rhBMP‐2) is a differentiation factor which has been shown to induce bone formation and heal bony defects in a variety of animal models. A possible application of rhBMP‐2 is to accelerate bone regeneration during distraction osteogenesis, which clinically is a long procedure, often involving significant complications. In this study we tested the ability of rhBMP‐2 to accelerate the consolidation phase of distraction osteogenesis in a rabbit model of leg lengthening. Tibiae were lengthened 2 cm over a period of ten days. rhBMP‐2 was administered at the end of the lengthening phase. Two modes of rhBMP‐2 application were tested: surgical implantation of rhBMP‐2/ACS (absorbable collagen sponge) into the regenerate (50 μl of 1.5 mg/ml rhBMP‐2, total dose = 75 μg rhBMP‐2), and percutaneous injection of rhBMP‐2/buffer (0.1 ml of 0.75 mg/ml rhBMP‐2, total dose = 75 μg rhBMP‐2) into three sites within the regenerate. Also, there were three groups of control animals: (1) no surgical intervention, (2) surgical implantation of buffer/ACS and (3) percutaneous injection of buffer. Rabbits were sacrificed at 5, 14 and 28 days after the interventions. Radiographic evaluation indicated a significant increase in bony union of the distraction regenerate in the rhBMP‐2 treated groups compared with the untreated groups at 5 and 14 days. At 28 days, formation of a cortex and reestablishment of the medullary canal was evident only in the rhBMP‐2 treated groups. The bone mineral content (BMC) of the regenerate was significantly higher in the rhBMP‐2 treated groups at 5 and 14 days. However, at 28 days, BMC of the regenerate was similar in all groups. The average volumetric density of the regenerate was significantly higher in the rhBMP‐2 injection group at day 14. In summary, both injection of rhBMP‐2/buffer and implantation of rhBMP‐2/ACS enhanced the consolidation stage of distraction osteogenesis in this rabbit model. © 2002 Orthopaedic Research Society. Published by Elsevier Science Ltd. All rights reserved.